Cognitive behavioral therapy for adults with ADHD and behavioral addictions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized pilot compares a 10-session standardized cognitive-behavioral therapy (CBT) program to treatment-as-usual in adults with co-occurring ADHD and behavioral addiction. Participants complete a baseline standardized assessment including seven self-report questionnaires (~45 minutes) covering symptoms, quality of life, impulsivity and emotion regulation, then receive either CBT or usual care and are reassessed 12 weeks after inclusion. The primary outcome is the 12-week retention rate, with additional symptom and functional measures collected at follow-up. The trial is conducted at outpatient addictology departments in three French university hospitals (Brest, Nantes, Tours).

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient over 18 (age ≥ 18 years)
* Patient treated in an outpatient addictology department at the CHU of Brest, Nantes or Tours and presenting an ADHD/behavioral addiction comorbidity
* Patient affiliated to a social security scheme
* For patients treated with methylphenidate: no change in treatment dosage during the previous three months.
* For patients not treated with methylphenidate: no introduction of methylphenidate within the next three months.

Exclusion Criteria:

* Patients with psychotic disorders (assessed by clinician)
* Pregnant or breast-feeding women
* Patients under protective supervision (guardianship or curatorship)
* Persons under court protection
* Persons deprived of their liberty
* Patients who do not meet the eligibility criteria for CBT (e.g., cognitive impairment, hearing impairment).
* Physical inability to participate in CBT sessions (e.g., lack of telephone, foreseeable unavailability).
* Difficulty understanding self-questionnaires, including illiteracy.
* Participation in another interventional research protocol involving another psychotherapeutic or pharmacological intervention that may have an impact on clinical outcome.

Where it's running

• CHRU De Tours
  Tours, France Recruiting
• CHU La Cavale Blanche
  Brest, France Not yet recruiting
• Centre Hospitalier Saint Jacques
  Nantes, France Active not recruiting

Study contacts

• Principal investigator: Servane BARRAULT, Dr — CHRU de Tours
• Study coordinator: Servane BARRAULT, Dr
• Email: s.barrault@chu-tours.fr
• Phone: (+33)2.47.47.91.91

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biomarkers that predict medication-related side effects in children with ADHD

  This study tests whether combined brain, cognitive, and metabolite markers can predict side effects from methylphenidate in kids with ADHD.

  Recruiting National Taiwan University Hospital · Taipei, Taiwan · NCT07900451

• Group CBT vs. Activity Group for Adults with ADHD

  This trial tests whether group cognitive behavioral therapy helps adults with ADHD more than a structured activity group.

  Recruiting at 2 sites Region Stockholm · Stockholm and 1 other locations · NCT07834437

• Central Executive Training and Behavioral Parent Training for Young Children with ADHD

  This study tests Central Executive Training (CET) alone and CET combined with Behavioral Parent Training (BPT) to help young children with ADHD.

  Recruiting Florida State University · Tallahassee, Florida · NCT07784348

• Solriamfetol for ADHD in teens: see if it helps with focus

  This phase 3 study tests solriamfetol versus placebo in adolescents with ADHD to see if the medication improves symptoms over 6 weeks.

  Recruiting at 31 sites Phase 3 Axsome Therapeutics, Inc. · Dothan, Alabama and 30 other locations · NCT07717892

• Solriamfetol for children with ADHD: a 6-week comparison to placebo

  This trial tests whether solriamfetol can help children aged 6 to under 12 with ADHD, compared to placebo, over six weeks.

  Recruiting at 32 sites Phase 3 Axsome Therapeutics, Inc. · Dothan, Alabama and 31 other locations · NCT07717879

• Impact of Sleep Timing and Duration on Teens with ADHD

  This study tests how changing how long and when teens with ADHD sleep affects their attention and daily functioning.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07684417

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.